Robert King to Neointima
This is a "connection" page, showing publications Robert King has written about Neointima.
Caroff J, Iacobucci M, Rouchaud A, Mihalea C, de Carvalho FM, Jocson VED, Chalumeau V, Da Ros V, King RM, Arslanian R, Ikka L, Ben Achour N, Moret J, Spelle L. The occurrence of neointimal hyperplasia after flow-diverter implantation is associated with cardiovascular risks factors and the stent design. J Neurointerv Surg. 2019 Jun; 11(6):610-613.
Caroff J, Tamura T, King RM, Lylyk PN, Langan ET, Brooks OW, Clarençon F, Wainwright JM, Spelle L, Marosfoi M, Gounis MJ, Puri AS. Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia. J Neurointerv Surg. 2018 Nov; 10(11):1097-1101.